Back to newsStarling Oncology raises target price to $9 from $7SSTLN•2026-10-14Needham raised its target price for Starling Oncology to $9 from $7.Related NewsPP&G: Citigroup raises target price to $180 from $170PG•2026-10-14WWaste Management target price cut to $259 from $269WM•2026-10-14JJ&J: Leerink Partners cuts target price to $272 from $276JNJ•2026-10-14NCitigroup raises ServiceNow target price to $170 from $154NOW•2026-10-14NNetApp: Barclays cuts to equal-weight from overweightNTAP•2026-10-14